Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to...

Related Keywords

Taiwan ,Shanghai ,China ,Xiayang Qiu ,Jiangxi ,Hong Kong ,Republic Of China ,Taiwan General ,Macau ,Eli Lilly ,Ruth Gimeno ,Regor Therapeutics Group ,Computer Accelerated Rational Discovery ,Generally Accepted Accounting Principles ,Eli Lilly And Company ,